Clinical trial
68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients
NCT05847348
Study timeline
Study start (actual)2023-07-19Date precision: day
Registry last updated2024-07-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
BCR Prostate Carcinomaunresolved
Interventions
68Ga-PSMA-11DRUG
PET/CT or PET/MRIOTHER
Sponsors & collaborators
Telix Pharmaceuticals (Innovations) Pty Limitedlead sponsor
Grand Pharmaceutical (China) Co., Ltd.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05847348 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.